The authors reported that although there was a mean decrease in the NIH-CPSI score of 40.5% and 44.0% in the treatment and placebo groups, respectively, and also a 67% and 64.3% positive response rate, respectively, their results did not reach statistical significance.
← all excerpts
Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome.
1
—
—